Christopher Palmer has been an associate editor at MDedge News since 2017. When he's not tidying grammar, he writes short pieces about breaking FDA announcements and approvals, as well as journal articles. He proudly holds a BA in English and philosophy. Follow him on Twitter @cmacmpalm.
News
Universal adolescent education on healthy relationships needed
There were no statistically significant demographic differences among girls facing reproductive coercion or adolescent relationship abuse.
News
Osteoporosis, osteoarthritis risk high among cerebral palsy patients
This is the first study to compare these risks using a relatively large cohort of adults with and without cerebral palsy.
News
CBT intervention tied to Internet addiction remission in men
The primary endpoint of remission, defined as a score of less than 7 on the AICA-S, was achieved by 50 patients (69.4%) in the treatment arm,...
News
Parent education improves pediatric influenza vaccination rates
Use of an educational handout before seeing a health care provider improved rates of pediatric influenza vaccination by the end of the season.
News
Acquired MMR immunity doesn’t last to age 1 year
Although infants are born with some protection passed on by their mothers, this does not last to 1 year of age.
News
Liraglutide indication expanded to include children
The approval marks the first noninsulin drug approved for pediatric use in almost 20 years.
News
Obesity and overweight declined among lower-income kids
The reduction still leaves 29.1% of 2 to 4-year-olds in the Supplemental Nutrition Program for WIC either overweight or obese.
News
Rosacea: Quality of life improves with treatment success
A National Rosacea Society survey suggests that the amount quality of life improves depends on degree of skin clearance.
News
Teva expands its recall of losartan lots
Some lots of this and other ARBs have been implicated in having high levels of possibly cancer-causing impurity.
News
FDA invites sample submission for FDA-ARGOS database
The project hopes to make diagnosing pathogens – including biothreats like Ebola and Zika – both easier and faster.
News
FDA approves Nucala’s new at-home formulations
Approved in 2015 for severe eosinophilic asthma, Nucala (mepolizumab) will now available as an autoinjector and as a prefilled safety syringe.
News
FDA: Vinpocetine associated with fetal harms, miscarriage
Although vinpocetine is an unregulated ingredient in many dietary supplements in the United States, it’s regulated as a prescription drug in some...
News
Timolol shortens propranolol use in infantile hemangioma
This is of interest because of the rare but serious adverse effects associated with propranolol.
News
FDA approves first drug for steroid-refractory acute GVHD
Ruxolitinib will be made available to appropriate patients immediately, according to Incyte.